Provided by Tiger Trade Technology Pte. Ltd.

Annovis Bio, Inc.

1.75
-0.0700-3.85%
Pre-market: 1.800.0500+2.86%04:00 EDT
Volume:670.72K
Turnover:1.18M
Market Cap:74.45M
PE:-0.98
High:1.83
Open:1.83
Low:1.74
Close:1.82
52wk High:5.50
52wk Low:1.54
Shares:42.54M
Float Shares:35.32M
Volume Ratio:1.11
T/O Rate:1.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7895
EPS(LYR):-1.4040
ROE:-703.68%
ROA:-142.36%
PB:-17.50
PE(LYR):-1.25

Loading ...

Annovis Bio Shareholders Approve Governance and Compensation Changes

TIPRANKS
·
Jun 18

Annovis Bio shareholders approve 2019 equity plan share increase to 5.5 million

Reuters
·
Jun 18

Annovis Bio: Buy Rating Reiterated as Late-Stage Neurodegenerative Pipeline Advances; $8 Price Target Unchanged

TIPRANKS
·
May 29

Annovis Bio Regains Nyse Listing Compliance

THOMSON REUTERS
·
May 26

Annovis Bio Regains NYSE Listing Compliance

GlobeNewswire
·
May 26

Annovis Bio director Michael B Hoffman buys $141,027 of common shares

Reuters
·
May 22

Annovis Bio Announces Dilutive Equity Offering for Trials

TIPRANKS
·
May 21

BRIEF-Annovis Announces Pricing Of $15.0 Million Public Offering Of Common Stock And Accompanying Warrants

Reuters
·
May 20

Annovis Bio 7.9M share Spot Secondary priced at $1.90

TIPRANKS
·
May 20

Annovis Announces Pricing of $15.0 Million Public Offering of Common Stock and Accompanying Warrants

THOMSON REUTERS
·
May 20

Annovis Bio Inc - Combined Offering Price per Share and Warrant Is $1.90

THOMSON REUTERS
·
May 20

Annovis Bio announces common stock and warrants offering, no amount given

TIPRANKS
·
May 20

Annovis Bio launches underwritten public offering of common stock with warrants

Reuters
·
May 20

Annovis Bio Inc - Proceeds to Fund Phase 3 Buntanetap Development and General Purposes

THOMSON REUTERS
·
May 20

Press Release: Annovis Announces Launch of Proposed Public Offering of Common Stock and Accompanying Warrants

Dow Jones
·
May 20

Annovis Bio Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
May 15

Annovis Bio Q1 EPS $(0.63) Misses $(0.40) Estimate

Benzinga Earnings
·
May 15

Annovis Bio Inc - Cash and Cash Equivalents $14.2 Mln as of March 31, 2026

THOMSON REUTERS
·
May 15

Press Release: Annovis Provides Corporate Updates and Reports First Quarter 2026 Financial Results

Dow Jones
·
May 15

Annovis Bio Inc expected to post a loss of 39 cents a share - Earnings Preview

Reuters
·
May 08